Pacira BioSciences, Inc. revenue for the last year amounted to 674.98 M USD, the most of which — 674.98 M USD — came from its highest performing source at the moment, Non-opioid Pain Management and Regenerative Health Solutions, the year earlier bringing 666.82 M USD. The greatest contribution to the revenue figure was made by United States, European Union, United Kingdom and Canada — last year it brought Pacira BioSciences, Inc. 674.98 M USD, and the year before that — 666.82 M USD.